Skip to content
Screener

Amneal Pharmaceuticals, Inc. AMRX Specialty — Materials and supplies

Other segment segments

Affordable Medicines
$8.8M+8.5%

Similar metrics at other companies

ABM Industries logo
ABMAviation — Materials and supplies
$3.8M+2.7%
ABM Industries logo
ABMEducation — Materials and supplies
$4.7M0.0%
ABM Industries logo
ABMTechnical Solutions — Materials and supplies
$33.4M+12.1%
ABM Industries logo
ABMB&I — Materials and supplies
$31.1M-12.4%
ABM Industries logo
ABMManufacturing And Distribution — Materials and supplies
$10.9M+49.3%
InfuSystem Holdings logo
INFUDevice Solutions — Supplies and material costs
$4.48M-1.5%

Other financials

Income statement

See full
Revenue$796.2M+9.9%
Gross profit$334.5M+16.9%
Operating income$129.8M+16.5%
Net income$57.7M+157%
EPS (diluted)$0.18+157%

Balance sheet

See full
Cash & equivalents$127.6M+78.4%
Total debt$2.6B+18.0%
Total equity$33.0M+129%
Total assets$3.8B+10.3%

Cash flow

See full
Operating cash flow-$21.2M-125%
CapEx$30.7M+34.5%
Free cash flow-$51.9M-185%

Valuation

See full
Market cap$5.77B+129%
Enterprise value$8.21B+77.4%
P/E36.7×-711×
P/S1.9×+1.0×

Profitability

See full
Gross margin39.3%+1.7pp
Operating margin14.6%+1.4pp
Net margin5%+4.9pp
FCF margin4.1%-5.8pp

Returns & leverage

See full
Return on equity-52.8%-12.7pp
Debt / equity77.8×
Current ratio2.2×+0.8×

Where this comes from

Reported directly by Amneal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SuppliesExpense.

The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001723128-26-000031
Line itemThree Months Ended June 30, 2026 / Affordable MedicinesThree Months Ended June 30, 2026 / SpecialtyThree Months Ended June 30, 2025 / Affordable MedicinesThree Months Ended June 30, 2025 / Specialty
Employee compensation and benefits$12,016$1,326$14,693$1,279
Materials and supplies8,7961,0228,108450
Product development and studies (1)(89)2,6157562,371
In-licensing and upfront milestones3,5006,350
Facilities costs1,479301,793735
Regulatory fees1,3342,932
Other (2)5,9871,0017,2671,230
Total$33,023$5,994$41,899$6,065

Item 1. Financial Statements (Unaudited)

FAQ

What is Amneal Pharmaceuticals, Inc.'s specialty — materials and supplies?
Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — materials and supplies of $1.02M in Q2 2026.
How has Amneal Pharmaceuticals, Inc.'s specialty — materials and supplies changed year-over-year?
Amneal Pharmaceuticals, Inc.'s specialty — materials and supplies increased by 127.1% year-over-year, from $450K to $1.02M.
What is the long-term trend for Amneal Pharmaceuticals, Inc.'s specialty — materials and supplies?
Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s specialty — materials and supplies has grown at a 31.9% compound annual growth rate (CAGR), from $1.31M to $3M.
What does specialty — materials and supplies mean?
Represents the direct costs of physical materials and consumables required for the daily operations of the specialty segment. Monitoring this helps identify fluctuations in input costs and operational resource consumption.

Ask your AI about Amneal Pharmaceuticals, Inc.'s specialty — materials and supplies.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude